IDenta Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDTA research report →
Companywww.identa-corp.com
IDenta Corp. develops, manufactures, and supplies field detection and home diagnostics testing kits for narcotics and explosives, and forensic products in the homeland security and consumer markets worldwide. The company offers drug, explosives, and bullet-hole testing kits; FerroPrint testing products; blood detection kits; precursors of drugs test kits; and portable sniffers.
- CEO
- Amichai Glattstein
- IPO
- 2017
- Employees
- 11
- HQ
- Jerusalem, IL
Price Chart
Valuation
- Market Cap
- $716.07K
- P/E
- 3.75
- P/S
- 0.42
- P/B
- 0.81
- EV/EBITDA
- 3.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 53.91%
- Op Margin
- 22.64%
- Net Margin
- 11.29%
- ROE
- 24.25%
- ROIC
- 24.01%
Growth & Income
- Revenue
- $1.34M · -7.86%
- Net Income
- $99.04K · -61.66%
- EPS
- $0.02 · -61.66%
- Op Income
- $185.37K
- FCF YoY
- -92.75%
Performance & Tape
- 52W High
- $0.56
- 52W Low
- $0.15
- 50D MA
- $0.19
- 200D MA
- $0.22
- Beta
- 0.94
- Avg Volume
- 1.89K
Get TickerSpark's AI analysis on IDTA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IDTA Coverage
We haven't published any research on IDTA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IDTA Report →